Private Wealth Partners' Q3 vs Q4 2022: Analyzing Changes in Top Holdings
Ava Hoppe | 23 April, 2023
Private Wealth Partners, LLC recently released their 13F holding report comparing the third quarter of 2022 to the fourth quarter of the same year. This report is used to disclose the fund's equity portfolio changes, including new buys, sells, and holdings. From the report, several changes to the fund's top holdings are worth noting.
Apple (AAPL) still held the top spot with 656,560 shares and a value of $90,737 in Q3 2022, however, Q4 saw an increase in the number of shares, with the value decreasing slightly by 3.2%. Similarly, the second-largest holding, Microsoft (MSFT), experienced a 8.8% increase in shares, and a rise in value from $63,942 in Q3 to $69,560 in Q4.
Other notable changes include:
- Merck & Co Inc (MRK) experienced a 30.7% increase in shares, moving up two spots to the sixth largest holding.
- Amazon (AMZN) fell from the fifth largest holding to the seventh largest, with a -23% decrease in value.
- Stryker Corporation (SYK) had a significant 38.2% increase in shares, moving up three spots to the 27th largest holding.
- SalesForce (CRM) saw a -25% decrease in value and dropped two spots to the 46th largest holding.
The report also reveals several new additions to the portfolio, such as Eaton Vance Mun Bd Fd (EIM), Bank Marin Bancorp (BMRC), and Pacer Fds Tr (holding unnamed). Meanwhile, iShares TR (TFLO), Goldman Sachs ETF Tr (GSST), and iShares TR (LQD) were among the holdings that no longer featured in the portfolio.
In conclusion, Private Wealth Partners' Q3 vs Q4 2022 holdings report reveals several notable changes in the fund's portfolio. While some stocks experienced an increase in shares and value, others experienced a decline. Additionally, several new additions to the portfolio and absences from the portfolio suggest that the fund is continually evolving and seeking to maximize returns for its investors.
Other Posts
- Comparing Tweedy, Browne Co LLC's Q3 2022 and Q4 2022 Holdings: Which Stocks Did They Buy and Sell?
- Summit Global Investments' Diverse Portfolio: Q3 2022 vs. Q4 2022 13F Holdings Comparison
- The Battle of Investments: Zevenbergen Capital Investments LLC Q3 2022 vs. Q4 2022
- Navigating Q3 and Q4 2022 13F Holdings: An Examination of Regal Partners Ltd's Portfolio Updates
- Reinhart Partners, LLC. Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Investment Insights: Oppenheimer & Close 13F Holdings Q3 2022 vs. Q4 2022
- Investing in 2023: Analyzing Acropolis Investment Management's 13F Holdings Shifts
- The Evolving Investment Strategy of Matlinpatterson Global Advisers: A Q2-Q3 Holdings Analysis
- The Rise and Fall of Belvedere Advisors LLC's Q1 vs. Q2 2019 Fund Holdings
- Navidea Biopharmaceuticals, Inc. Sets its Sights on Future Growth and Rejects Unsolicited Offer